BlackRock Institutional Trust’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $19.8M | Buy |
1,434,807
+159,346
| +12% | +$2.2M | ﹤0.01% | 1970 |
|
|
2016
Q3 | $23M | Buy |
1,275,461
+181,063
| +17% | +$3.27M | ﹤0.01% | 1788 |
|
|
2016
Q2 | $15.7M | Sell |
1,094,398
-12,810
| -1% | -$184K | ﹤0.01% | 2000 |
|
|
2016
Q1 | $13.2M | Buy |
1,107,208
+6,770
| +0.6% | +$80.9K | ﹤0.01% | 2085 |
|
|
2015
Q4 | $14.6M | Buy |
1,100,438
+17,225
| +2% | +$229K | ﹤0.01% | 2072 |
|
|
2015
Q3 | $11.6M | Sell |
1,083,213
-107,418
| -9% | -$1.15M | ﹤0.01% | 2187 |
|
|
2015
Q2 | $9.59M | Buy |
1,190,631
+29,178
| +3% | +$235K | ﹤0.01% | 2432 |
|
|
2015
Q1 | $7.68M | Buy |
1,161,453
+67,140
| +6% | +$444K | ﹤0.01% | 2553 |
|
|
2014
Q4 | $6.97M | Buy |
1,094,313
+43,666
| +4% | +$278K | ﹤0.01% | 2561 |
|
|
2014
Q3 | $10.4M | Buy |
1,050,647
+709
| +0.1% | +$7K | ﹤0.01% | 2312 |
|
|
2014
Q2 | $11.8M | Buy |
1,049,938
+1,825
| +0.2% | +$20.6K | ﹤0.01% | 2322 |
|
|
2014
Q1 | $12.7M | Buy |
1,048,113
+21,320
| +2% | +$258K | ﹤0.01% | 2263 |
|
|
2013
Q4 | $12.9M | Sell |
1,026,793
-64,221
| -6% | -$809K | ﹤0.01% | 2244 |
|
|
2013
Q3 | $18.2M | Sell |
1,091,014
-45,870
| -4% | -$764K | ﹤0.01% | 1934 |
|
|
2013
Q2 | $17.3M | Buy |
+1,136,884
| New | +$17.3M | ﹤0.01% | 1916 |
|